Literature DB >> 28506418

Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.

Andrea Polistena1, Alessandro Sanguinetti2, Roberta Lucchini3, Sergio Galasse4, Massimo Monacelli5, Stefano Avenia6, Andrea Boccolini7, Louis Banka Johnson8, Nicola Avenia9.   

Abstract

BACKGROUND: Medullary thyroid carcinoma is an aggressive tumor and presents with significant morbidity and mortality and a high rate of lymph node metastases. The combination of total thyroidectomy and cervical lymphadenectomy is the essential treatment for those patients presenting with cervical lymph node metastases.
MATERIALS AND METHODS: A retrospective analysis of 117 patients operated for medullary thyroid carcinoma over a period of 15 years at a single institution. Surgical complications and calcitonin levels were noted.
RESULTS: Nodal metastases were detected in the central compartment in 72.6% patients. Positive lymph nodes were detected in the lateral compartment of 34 patients who had undergone ipsilateral dissection and in all 10 patients of those with bilateral surgery. We found 3 cases of unilateral transient recurrent laryngeal nerve palsy, 15 cases of temporary hypoparathyroidism, a permanent accessory nerve lesion and a case of chylous fistula. Normalization of post-operative calcitonin was found in 82.6% and of patients who underwent total thyroidectomy and central neck dissection alone compared to 35.4% in those with ipsilateral and bilateral neck dissection.
CONCLUSIONS: Total thyroidectomy and cervical lymphadenectomy planned on the ultrasound preoperative study and on the calcitonin level represent the standard of treatment for medullary thyroid carcinoma.
Copyright © 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carcinoma; Lymph node; Medullary; Metastases; Surgery; Thyroid; Ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28506418     DOI: 10.1016/j.ijsu.2017.04.026

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.

Authors:  O Hamdy; S Awny; I H Metwally
Journal:  Ann R Coll Surg Engl       Date:  2020-04-01       Impact factor: 1.891

2.  The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway.

Authors:  Else Marie Opsahl; Lars Andreas Akslen; Ellen Schlichting; Turid Aas; Katrin Brauckhoff; Anne Irene Hagen; Alf Frimann Rosenlund; Eva Sigstad; Krystyna K Grøholt; Lars H Jørgensen; Trine Bjøro
Journal:  Eur Thyroid J       Date:  2019-04-29

3.  Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.

Authors:  L D Juez; E Mercader; I Amunategui; B Febrero; J M Rodríguez; J Gómez-Ramírez
Journal:  World J Surg       Date:  2022-01-28       Impact factor: 3.352

Review 4.  Management of lymph nodes in medullary thyroid carcinoma: A review.

Authors:  Ali Shaghaghi; Abolfazl Salari; Amirmohsen Jalaeefar; Mohammad Shirkhoda
Journal:  Ann Med Surg (Lond)       Date:  2022-09-03

5.  Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.

Authors:  Liuqing Ye; Xi Zhou; Jie Lu; Yanzhong Wang; Xinyou Xie; Jun Zhang
Journal:  J Clin Lab Anal       Date:  2020-03-06       Impact factor: 2.352

6.  Nodal disease burden and outcome of medullary thyroid carcinoma.

Authors:  Lindsey E Moses; Jamie R Oliver; Janine M Rotsides; Qianhui Shao; Kepal N Patel; Luc G T Morris; Babak Givi
Journal:  Head Neck       Date:  2020-10-27       Impact factor: 3.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.